JOURNAL OF SEXUAL MEDICINE, vol.6, pp.340-346, 2009 (SCI-Expanded)
Introduction. Immunophilin ligands provide potentially new alternatives for the treatment of erectile dysfunction (ED), which occurs after injury of the cavernous nerves (CNs).